Hanson & Doremus Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.95M Sell
10,917
-268
-2% -$91.7K 0.4% 37
2026
Q1
$3.94M Buy
11,185
+138
+1% +$49.2K 0.45% 37
2025
Q4
$3.62M Sell
11,047
-310
-3% -$98.3K 0.43% 37
2025
Q3
$3.21M Buy
11,357
+10
+0.1% +$2.9K 0.4% 41
2025
Q2
$3.17M Buy
11,347
+1,422
+14% +$403K 0.42% 44
2025
Q1
$3.09M Buy
9,925
+8,405
+553% +$2.48M 0.45% 44
2024
Q4
$396K Hold
1,520
0.06% 124
2024
Q3
$490K Sell
1,520
-72
-5% -$23.6K 0.08% 109
2024
Q2
$497K Buy
1,592
+55
+4% +$16.2K 0.08% 111
2024
Q1
$437K Buy
1,537
+98
+7% +$28.7K 0.08% 120
2023
Q4
$414K Hold
1,439
0.08% 123
2023
Q3
$387K Hold
1,439
0.08% 124
2023
Q2
$319K Hold
1,439
0.07% 138
2023
Q1
$348K Sell
1,439
-348
-19% -$85.4K 0.08% 133
2022
Q4
$469K Buy
1,787
+348
+24% +$93.3K 0.1% 124
2022
Q3
$324K Hold
1,439
0.08% 133
2022
Q2
$350K Hold
1,439
0.09% 133
2022
Q1
$348K Buy
1,439
+590
+69% +$136K 0.07% 144
2021
Q4
$191K Hold
849
0.04% 188
2021
Q3
$181K Sell
849
-20
-2% -$4.6K 0.04% 181
2021
Q2
$221K Sell
869
-96
-10% -$23.6K 0.07% 152
2021
Q1
$240K Buy
965
+16
+2% +$3.82K 0.06% 167
2020
Q4
$218K Buy
949
+80
+9% +$18.4K 0.05% 167
2020
Q3
$221K Hold
869
0.07% 152
2020
Q2
$205K Sell
869
-80
-8% -$18.3K 0.06% 153
2020
Q1
$192K Buy
949
+17
+2% +$3.71K 0.07% 155
2019
Q4
$225K Sell
932
-84
-8% -$18.5K 0.06% 159
2019
Q3
$197K Sell
1,016
-89
-8% -$17.1K 0.06% 169
2019
Q2
$204K Hold
1,105
0.06% 172
2019
Q1
$210K Buy
1,105
+45
+4% +$8.59K 0.07% 162
2018
Q4
$206K Hold
1,060
0.07% 157
2018
Q3
$220K Sell
1,060
-97
-8% -$19.1K 0.07% 169
2018
Q2
$214K Sell
1,157
-114
-9% -$20.2K 0.07% 169
2018
Q1
$217K Buy
1,271
+80
+7% +$14.7K 0.07% 181
2017
Q4
$207K Hold
1,191
0.07% 176
2017
Q3
$222K Hold
1,191
0.08% 168
2017
Q2
$205K Hold
1,191
0.08% 167
2017
Q1
$195K Hold
1,191
0.08% 167
2016
Q4
$174K Hold
1,191
0.08% 170
2016
Q3
$199K Hold
1,191
0.09% 157
2016
Q2
$181K Buy
1,191
+35
+3% +$5.44K 0.08% 162
2016
Q1
$173K Sell
1,156
-45
-4% -$6.69K 0.08% 164
2015
Q4
$195K Buy
1,201
+300
+33% +$47.2K 0.09% 163
2015
Q3
$125K Sell
901
-20
-2% -$3.15K 0.06% 190
2015
Q2
$141K Hold
921
0.06% 189
2015
Q1
$147K Sell
921
-35
-4% -$5.51K 0.06% 188
2014
Q4
$152K Hold
956
0.07% 185
2014
Q3
$134K Hold
956
0.06% 191
2014
Q2
$113K Sell
956
-50
-5% -$5.79K 0.05% 204
2014
Q1
$124K Sell
1,006
-85
-8% -$10.3K 0.06% 194
2013
Q4
$124K Sell
1,091
-100
-8% -$11.4K 0.06% 185
2013
Q3
$133K Hold
1,191
0.07% 175
2013
Q2
$118K Buy
+1,191
New +$124K 0.06% 174

Other funds holding AMGN

Hanson & Doremus Investment Management's AMGN Position: Q2 2026 in Review

Hanson & Doremus Investment Management reduced its Amgen (AMGN) stake by 2.4% in Q2 2026, selling an estimated $91.7K and leaving 10,917 shares worth $3.95M. The position accounts for 0.4% of the portfolio, ranked #37.

Hanson & Doremus Investment Management first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Hanson & Doremus Investment Management held 10,917 shares of Amgen worth $3.95M as of Q2 2026.
  • Hanson & Doremus Investment Management sold 268 Amgen shares in Q2 2026, an estimated $91.7K.
  • Amgen made up 0.4% of Hanson & Doremus Investment Management's portfolio in Q2 2026, its #37 holding.
  • Hanson & Doremus Investment Management first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Hanson & Doremus Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.